gobalto videos

  1. Will Decentralized Trials Create Technology Integration Problems? 4/14/2021

    In this webinar segment, Tero Laulajainen, VP and head of global clinical science and operations for UCB, and Hassan Kadhim, global head of clinical trial business capabilities, clinical innovation, and industry collaborations at Bristol-Myers Squibb, discuss decentralized trials, new technologies, and integration issues that can arise when converting studies to a virtual model.

  2. Is AI Improving Outcomes In Clinical Trials? 11/13/2020

    The complexity of initiating clinical studies continues to grow. The complexity is a confluence of complicated protocols, globalization, and regulatory changes, all at a time when there is intense pressure to restrain costs and shorten timelines. The key to reducing these complexities is the ability to use machine learning to gain critical operational insights, which will allow organizations to learn and adapt. The insights gained will allow organizations to transition from subjective decisions to data-driven decisions.

  3. Is Pharma Ready To Embrace Virtual Trials? 7/13/2020

    For years, technology vendors have pitched the benefits of virtual (decentralized) trials. Virtual trials are patient-centric and site-centric and can produce cost and efficiency benefits for sponsor companies. While adoption has been slow, the COVID-19 pandemic suddenly has companies scrambling for solutions that will protect patients and relieve the burden on sites. But are sponsors ready to embrace virtual trials?